Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMS-02: Doxorubicin + Trabectedin in Leiomyosarcoma
NCT02131480Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- Jun 2010
- Primary completion
- Jan 2013
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in leiomyosarcoma (LMS), sponsored by Gustave Roussy. Started Jun 2010; status: completed.
02
Drugs
trabectedin
03
Conditions
leiomyosarcoma (LMS)
Beyond the preview
Go deeper on NCT02131480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02131480.